ATE468157T1 - Lipoxinanaloge als neuartige restenose-hemmer - Google Patents

Lipoxinanaloge als neuartige restenose-hemmer

Info

Publication number
ATE468157T1
ATE468157T1 AT08006250T AT08006250T ATE468157T1 AT E468157 T1 ATE468157 T1 AT E468157T1 AT 08006250 T AT08006250 T AT 08006250T AT 08006250 T AT08006250 T AT 08006250T AT E468157 T1 ATE468157 T1 AT E468157T1
Authority
AT
Austria
Prior art keywords
lipoxine
restenose
analogues
inhibitors
novel
Prior art date
Application number
AT08006250T
Other languages
English (en)
Inventor
Charles N Serhan
Iolanda M Fierro
Original Assignee
Brigham & Womens Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brigham & Womens Hospital filed Critical Brigham & Womens Hospital
Application granted granted Critical
Publication of ATE468157T1 publication Critical patent/ATE468157T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT08006250T 2001-03-02 2002-03-01 Lipoxinanaloge als neuartige restenose-hemmer ATE468157T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27293101P 2001-03-02 2001-03-02

Publications (1)

Publication Number Publication Date
ATE468157T1 true ATE468157T1 (de) 2010-06-15

Family

ID=42221185

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08006250T ATE468157T1 (de) 2001-03-02 2002-03-01 Lipoxinanaloge als neuartige restenose-hemmer

Country Status (5)

Country Link
EP (1) EP1949937B1 (de)
AT (1) ATE468157T1 (de)
DE (1) DE60236467D1 (de)
ES (1) ES2344814T3 (de)
HK (1) HK1118744A1 (de)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6048897A (en) * 1993-06-15 2000-04-11 Brigham And Women's Hospital Lipoxin compounds and their use in treating cell proliferative disorders
WO2000009503A1 (en) 1998-08-13 2000-02-24 Merck & Co., Inc. Integrin receptor antagonists
AU3846801A (en) 2000-02-16 2001-08-27 Brigham & Womens Hospital Aspirin-triggered lipid mediators

Also Published As

Publication number Publication date
HK1118744A1 (en) 2009-02-20
DE60236467D1 (de) 2010-07-01
EP1949937A1 (de) 2008-07-30
EP1949937B1 (de) 2010-05-19
ES2344814T3 (es) 2010-09-07

Similar Documents

Publication Publication Date Title
ATE412448T1 (de) Lipoxin analoge als neue inhibitoren der angiogenese
MY144232A (en) 5-substituted-2-phenylamino benzamides as mek inhibitors
ATE469674T1 (de) 5-aminolävulinsäure-derivate zur behandlung von akne
CY1108725T1 (el) Συνδυασμος ανταγωνιστου-nmda και αναστολεων ακετυλοχολινεστερασης δια την θεραπειαν της νοσου alzheimer
MXPA03010435A (es) Derivados de oxazol acido carboxilico sustituidos para uso como activadores de proliferacion del peroximosa(ppar-alfa y gama) en el tratamiento de diabetes.
PT1983000E (pt) Método para o tratamento de esclerose múltipla através da inibição da atividade de il-17
DK0699439T3 (da) Behandling af sygdomme forårsaget af talgkirtellidelser med acyl-CoA-cholesterolacyltransferaseinhibitorer
ATE468157T1 (de) Lipoxinanaloge als neuartige restenose-hemmer
HUP0203025A2 (hu) Migrén kezelése alfa-liponsav és származékainak alkalmazásával
BR0311524A (pt) Terapia de combinação para o tratamento de esclerose lateral amiotrófica (als) com inibidor(es) de ciclooxigenase-2 (cox 2) e uma segunda droga
ATE352317T1 (de) Therapeutische behandlung von eosinophilie durch verwendung von chymase-inhibitoren als aktiven bestandteilen
ES2147499A1 (es) Derivados de acidos carboxilicos, metodo para su elaboracion y agentes terapeuticos que contienen estos compuestos.
EA200501083A1 (ru) Соединения, активные в ингибировании пролилолигопептидазы
WO2001060174A3 (en) Weight loss induced by reduction in neuropeptide y level
WO2001055108A3 (en) Use of spl a2 inhibitors for the treatment of inflammation

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties